This presentation will include an overview of the global epidemiology of tuberculosis in children, including the impact of HIV, and with specific emphasis on emerging data on drug-resistant TB.
Data will be presented on the historical challenges of evaluating existing and novel treatment strategies for TB in children. Emerging research opportunities and key early findings from pharmacokinetic studies and trials will be highlighted, addressing key pediatric populations including HIV-infected children, the treatment and prevention of MDR-TB, the use of novel drugs, and special treatment needs in infants and adolescents. An overview of research priories and planned and ongoing trials will be presented, and a framework to the evaluation of new TB drugs and regimens discussed.
Diagnostic challenges and new approaches to the diagnosis of TB, including novel biomarkers, molecular approaches and novel sampling strategies will be reviewed and global collaborative research efforts highlighted.